iSERA LIFESCIENCES share price & results

iSERA LIFESCIENCES LIMITED

Results to: Jun 2019
Ownership as of: Jun 2026

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

Metric	Value	Change	Basis	Period	Note
Revenue	1.1 ₹ crore	−89.4% YoY	Quarterly, as filed	Quarter to Jun 2019	Revenue from operations as filed.
Operating margin	0.0 %	−0.8 pts YoY	Operating profit / revenue	Quarter to Jun 2019	For the quarter; a change is in percentage points.
Net profit	-0.06 ₹ crore	−400.0% YoY	Quarterly, as filed	Quarter to Jun 2019	Profit after tax as filed.
Return on equity	Unavailable	−9.8 ptsFY Mar 2019 vs FY Mar 2018	Trailing twelve months	TTM · period unavailable	Not in the analysed materials. No older figure is substituted.
Free cash flow margin	Unavailable	+0.7 ptsFY Mar 2019 vs FY Mar 2018	Fiscal year	FY · period unavailable	Not in the analysed materials. No older figure is substituted.
Revenue growth (YoY)	Unavailable	−154.0 ptsFY Mar 2019 vs FY Mar 2016	Trailing twelve months	TTM · period unavailable	Not in the analysed materials. No older figure is substituted.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2019

Price

₹143.9 0.00% · ₹0

Last close 13 Oct 2026 · NSE · INR

Performance +1467.5% 1Y

1Y: ₹9.18 on 10 Oct 2025 → ₹143.9. High ₹151.05 (17 Sept 2026), low ₹7.99 (30 Oct 2025).

Previous close: ₹143.9
Market cap: ₹65 Cr
52-week range: ₹7.99 – ₹151.05
One year: +1437.39%

Overview

Symbol: NSE:COVIDH
Exchange: NSE
Currency: INR

Fundamentals

Ratios, each with its period

Current values with the period they cover; the trend reads across the 6 fiscal years held (Mar 2013 to Mar 2019).

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2018 Mar 2019
— — — — — —

How it is calculated. Market capitalisation from the current stock record.

Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2018	Mar 2019
—	—	—	—	—	—

A dash means inputs are missing or too old, the ratio does not apply, or the value is outside the supported range. FY uses the reported fiscal period; TTM the latest twelve months; valuations use the current market cap with the chosen earnings period. Screen Indian stocks on these ratios →

Financials

What the filings say

Net profit, year on year: −400% (quarter to jun 2019 against jun 2018).

In ₹ crore. Oldest period first.

Line item	Jun 2015	Sept 2015	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019
Sales	4	6	14	10	7	4	4	1
Expenses	4	6	14	10	7	4	3	1
Operating profit	0	0	0	0	0	0	0	0
Operating margin	4.5%	3.5%	1.4%	0.8%	1.4%	2.1%	5.8%	0.0%
Other income	0	0	0	0	0	0	0	0
Interest	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0
Profit before tax	0	0	-0	0	-0	-0	-0	-0
Tax rate	27.3%	30.8%	−100.0%	33.3%	0.0%	0.0%	100.0%	0.0%
Net profit	0	0	0	0	-0	-0	-0	-0
EPS (₹ per share)	0	0	0	0	0	0	0	0

Source: Inve data · income statement, quarterly · to Jun 2019

In ₹ crore. Oldest period first.

Line item	Mar 2015	Mar 2019
Sales	11	26
Expenses	10	25
Operating profit	1	0
Other income	0	0
Interest	0	0
Depreciation	1	0
Profit before tax	0	-0
Net profit	0	-0

Source: Inve data · income statement, annual · to Mar 2019

In ₹ crore. Oldest period first.

Line item	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2018	Mar 2019
Equity capital	11	11	11	11	11	11
Reserves	3	3	3	-10	-10	-10
Borrowings	2	6	6	8	10	11
Other liabilities	6	6	5	6	10	7
Total liabilities	22	25	25	14	20	18
Fixed assets	6	6	8	1	1	1
Capital work in progress	6	5	4	0	0	0
Investments	0	0	0	0	0	0
Other assets	10	13	12	14	19	17
Total assets	22	25	25	14	20	18

Source: Inve data · balance sheet · to Mar 2019

In ₹ crore. Oldest period first.

Line item	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2018	Mar 2019
Cash from operations	-2	—	0	1	-1	-0
Cash from investing	-7	—	-1	-0	-0	-0
Cash from financing	9	—	1	-0	1	1
Net cash flow	0	—	0	-0	-0	0
Free cash flow	-5	—	0	0	-1	-0

Source: Inve data · cash flow · to Mar 2019

In days and %. Oldest period first.

Line item	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2018	Mar 2019
Debtor days	115	111	275	157	185	203
Inventory days	—	—	—	—	0	0
Cash conversion cycle	115	111	275	157	185	203
Working capital days	56	77	260	82	83	103
Return on capital employed	27.9%	1.2%	0.6%	1.6%	—	3.4%
Dividend payout	27.5%	0.0%	0.0%	0.0%	0.0%	0.0%

Source: Inve data · annual ratios · to Mar 2019

Ownership

Who owns it

Promoters hold 58.63% as of Jun 2026.

Promoters 0.00 pts 58.63%
Public −0.01 pts 41.37%

1,014 shareholders on the register.

Source: Exchange shareholding filings · to Jun 2026 · 8 filings held

Who was buying across the market this quarter

Who is on the register

Named in the Jun 2026 filing

Every holder of iSERA LIFESCIENCES LIMITED above SEBI's 1% disclosure line, and what changed since Mar 2026.

Holder	Stake	Change
Nandkumar Subhash Kadam	13.26%	unchanged
Dhairyasheel Vasantrao Yadav	13.26%	unchanged
Shubhangi Dhanraj Garad	9.51%	unchanged
Archana Kakasaheb Lonkar	8.32%	unchanged
Pratap Dadasaheb Deshmukh	6.54%	unchanged
Neville Maneckji	4.31%	unchanged
Ganapa Narsi Reddy	3.57%	unchanged
Sharmila Pratap Deshmukh	2.97%	unchanged
Laukik Pratap Deshmukh	2.38%	unchanged
Sumeet Dhanraj Garad	1.19%	unchanged
Ritu Dhanraj Garad	1.19%	unchanged
Kunaal Deepak Agashe	1.19%	unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Your own record

Start an Inve Case for iSERA LIFESCIENCES LIMITED

Free account: one company. Everything above stays public.

Write why you follow iSERA LIFESCIENCES LIMITED and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

Create your Inve Case What an account adds

Learn to analyse iSERA LIFESCIENCES LIMITED

Guides on how to read this kind of business and the numbers that matter.